Study links amygdala astrocytes to the strength and persistence of fear memories in mice

Astrocytes—star-shaped glial cells long cast mainly as support staff for neurons—appear to actively shape how fear memories are learned, recalled and weakened, according to a mouse study published in Nature. The work suggests these cells help sustain the neural activity patterns that underlie fear expression, a finding that researchers say could eventually inform new approaches to anxiety-related disorders.

A multi-institutional research team led by Andrew Holmes and Olena Bukalo of the National Institutes of Health’s Laboratory of Behavioral and Genomic Neuroscience, working with University of Arizona neuroscientist Lindsay Halladay, reports evidence that astrocytes in the amygdala help regulate fear memories in mice.

In experiments focused on the amygdala—a brain region central to fear processing—the researchers tracked astrocyte activity using fluorescent calcium sensors. Astrocyte activity increased during fear learning and during recall, and declined as fear responses were extinguished, according to a University of Arizona account of the work.

The team then tested whether changing astrocyte signaling could alter behavior. By experimentally strengthening or weakening astrocyte activity, the researchers were able to increase or reduce the strength of learned fear responses in mice, the report said.

Halladay described the results as evidence that astrocytes participate directly in the brain’s fear circuitry. “For the first time, we found that astrocytes encode and maintain neural fear signaling,” she said.

The study also links astrocyte activity to the stability of neuron population patterns associated with fear. When astrocyte signaling was disrupted, neurons were less able to form normal fear-related activity patterns, and communication across the broader fear-related circuit was impaired, the researchers reported.

The authors said the findings add to growing evidence that fear and memory processes are not driven by neurons alone. While the work was conducted in mice and does not by itself establish new treatments, the researchers argued that understanding how astrocytes influence fear expression and extinction could eventually help inform strategies for conditions marked by persistent or inappropriate fear, including anxiety disorders.

The study was published in Nature and is associated with DOI: 10.1038/s41586-025-10068-0.

Mga Kaugnay na Artikulo

Microscopic view of astrocytes clearing Alzheimer's amyloid plaques in a mouse brain, boosted by Sox9 protein.
Larawang ginawa ng AI

Boosting Sox9 protein helps astrocytes clear Alzheimer’s plaques in mice

Iniulat ng AI Larawang ginawa ng AI Fact checked

Researchers at Baylor College of Medicine report that raising levels of the protein Sox9 in astrocytes enables these brain support cells to remove existing amyloid plaques and preserve cognitive performance in mouse models of Alzheimer’s disease that already show memory deficits. The findings, published in Nature Neuroscience, highlight astrocytes as a potential target for slowing neurodegenerative decline.

Astrocytes—cells once widely described primarily as neuronal support—may be key intermediaries in how the brain translates a post-meal rise in glucose into satiety signals, according to a study published April 6, 2026, in the Proceedings of the National Academy of Sciences.

Iniulat ng AI Fact checked

Scientists at Cedars-Sinai Medical Center report that a subset of astrocytes located away from a spinal cord injury can help drive repair in mice by releasing the protein CCN1, which alters microglia metabolism to improve cleanup of lipid-rich nerve debris. The work, published in Nature, also found evidence of a similar CCN1-linked response in human spinal cord tissue from people with multiple sclerosis.

A study published November 5 in Nature reports that a small subset of microglia marked by low PU.1 and expression of the receptor CD28 can dampen neuroinflammation and curb amyloid pathology in Alzheimer’s models, pointing to microglia-focused immunotherapy. The work draws on mouse experiments, human cells, and analyses of human brain tissue.

Iniulat ng AI

Researchers at UNSW Sydney have identified around 150 functional DNA enhancers in human astrocytes that regulate genes associated with Alzheimer's disease. By testing nearly 1,000 potential switches using advanced genetic tools, the team revealed how non-coding DNA influences brain cell activity. The findings, published on December 18 in Nature Neuroscience, could aid in developing targeted therapies and improving AI predictions of gene control.

Researchers at UCLA Health and UC San Francisco have identified a natural defense mechanism in brain cells that helps remove toxic tau protein, potentially explaining why some neurons resist Alzheimer's damage better than others. The study, published in Cell, used CRISPR screening on lab-grown human neurons to uncover this system. Findings suggest new therapeutic avenues for neurodegenerative diseases.

Iniulat ng AI

A new study links temporal lobe epilepsy to early aging in brain support cells, showing that clearing these cells in mice reduces seizures and improves memory. Researchers at Georgetown University Medical Center used existing drugs to achieve these results, offering potential for faster treatments in humans. The findings, published on December 22, highlight hope for patients resistant to current medications.

 

 

 

Gumagamit ng cookies ang website na ito

Gumagamit kami ng cookies para sa analytics upang mapabuti ang aming site. Basahin ang aming patakaran sa privacy para sa higit pang impormasyon.
Tanggihan